Retour aux projets

18366.1 PFLS-LS

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis

Résumé

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis

Textes supplémentaires

Abstract

This feasibility project presents a lead peptide with promising anti-biofilm properties, which we aim to develop|into a drug candidate for the treatment of Pseudomonas infection in cystic fibrosis (CF) patients. The novel|mechanism of action utilized by this drug would create a niche in the CF drug market. The intellectual property|(IP) arising from this project will serve as the basis for the establishment of a company and further|development to bring the drug to the market.

Participants

Urs Jenal

Kontaktperson

urs.jenal@unibas.ch

Universität Basel Biozentrum Urs Jenal Spitalstrasse 41 4056 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-01-31
Date de fin
2017-07-31
Coûts totaux approuvés
CHF 352698.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%